| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
10,344 |
9,402 |
$906K |
| J3490 |
Unclassified drugs |
8,232 |
4,293 |
$478K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,390 |
1,305 |
$283K |
| A4649 |
Surgical supply; miscellaneous |
3,305 |
1,677 |
$240K |
| 0360 |
|
2,085 |
1,925 |
$236K |
| 85027 |
|
8,833 |
8,131 |
$193K |
| 81025 |
|
2,912 |
2,715 |
$157K |
| 0160 |
|
453 |
260 |
$139K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
716 |
688 |
$117K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
778 |
772 |
$100K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
489 |
480 |
$99K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
421 |
410 |
$69K |
| 80053 |
Comprehensive metabolic panel |
7,716 |
7,220 |
$67K |
| 71046 |
Radiologic examination, chest; 2 views |
1,338 |
1,319 |
$66K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,699 |
1,598 |
$65K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
790 |
730 |
$64K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
558 |
555 |
$58K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,544 |
3,483 |
$58K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
863 |
817 |
$55K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,239 |
1,221 |
$52K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,237 |
1,220 |
$47K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
754 |
747 |
$41K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
116 |
114 |
$41K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,662 |
3,644 |
$39K |
| 0710 |
|
1,754 |
1,749 |
$38K |
| 81000 |
|
1,945 |
1,886 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
605 |
577 |
$25K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
86 |
85 |
$24K |
| 83721 |
|
2,390 |
2,383 |
$24K |
| 81002 |
|
352 |
348 |
$22K |
| 83718 |
|
2,478 |
2,468 |
$21K |
| 73562 |
|
343 |
308 |
$18K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
164 |
123 |
$18K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
278 |
274 |
$17K |
| 84478 |
|
2,634 |
2,624 |
$16K |
| 70450 |
Computed tomography, head or brain; without contrast material |
366 |
359 |
$15K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
345 |
344 |
$15K |
| 74018 |
|
338 |
335 |
$14K |
| 80069 |
|
166 |
145 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
790 |
788 |
$13K |
| 82465 |
|
2,620 |
2,608 |
$13K |
| 0270 |
|
175 |
156 |
$13K |
| C1781 |
Mesh (implantable) |
13 |
13 |
$13K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
509 |
508 |
$13K |
| 73610 |
|
227 |
218 |
$13K |
| 86703 |
|
2,108 |
2,043 |
$12K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
145 |
145 |
$12K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
334 |
334 |
$12K |
| 82746 |
|
667 |
662 |
$11K |
| 73630 |
|
175 |
159 |
$11K |
| 86140 |
|
2,204 |
2,079 |
$9K |
| 86803 |
|
553 |
551 |
$9K |
| 76830 |
Ultrasound, transvaginal |
166 |
166 |
$9K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
125 |
125 |
$8K |
| 86780 |
|
521 |
514 |
$7K |
| J7050 |
Infusion, normal saline solution, 250 cc |
57 |
54 |
$7K |
| 73110 |
|
118 |
113 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
942 |
913 |
$6K |
| 86850 |
|
361 |
348 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
671 |
649 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,070 |
1,023 |
$6K |
| 93975 |
|
45 |
43 |
$5K |
| 84439 |
|
536 |
531 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,242 |
1,222 |
$5K |
| 84702 |
|
191 |
140 |
$5K |
| 87340 |
|
405 |
402 |
$4K |
| 87088 |
|
709 |
674 |
$4K |
| 73130 |
|
55 |
51 |
$4K |
| 81003 |
|
276 |
276 |
$4K |
| 82728 |
|
278 |
274 |
$4K |
| 73030 |
|
67 |
64 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,284 |
1,266 |
$4K |
| 83655 |
|
509 |
508 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
481 |
425 |
$4K |
| 82043 |
|
489 |
486 |
$3K |
| 83013 |
|
42 |
42 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,555 |
1,480 |
$3K |
| 86003 |
|
19 |
14 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
682 |
564 |
$3K |
| 88304 |
|
300 |
300 |
$3K |
| 87503 |
|
406 |
404 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
870 |
753 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
619 |
575 |
$3K |
| 85610 |
|
1,079 |
973 |
$2K |
| 84403 |
|
85 |
84 |
$2K |
| 83550 |
|
283 |
281 |
$2K |
| 83540 |
|
312 |
310 |
$2K |
| 86762 |
|
128 |
126 |
$2K |
| 85730 |
|
784 |
737 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
18 |
14 |
$2K |
| 85018 |
|
621 |
619 |
$2K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
70 |
70 |
$2K |
| 86480 |
|
25 |
25 |
$2K |
| 73080 |
|
14 |
14 |
$2K |
| 85014 |
|
595 |
591 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
81 |
81 |
$2K |
| 85651 |
|
575 |
557 |
$1K |
| 87186 |
|
324 |
312 |
$1K |
| 83735 |
|
2,975 |
2,697 |
$1K |
| 83880 |
|
191 |
187 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
447 |
423 |
$1K |
| 87070 |
|
45 |
41 |
$1K |
| 20610 |
|
41 |
41 |
$1K |
| 73140 |
|
13 |
13 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
27 |
27 |
$1K |
| 86901 |
|
398 |
383 |
$1K |
| 83690 |
|
2,887 |
2,677 |
$1K |
| 86705 |
|
83 |
82 |
$996.68 |
| 82550 |
|
912 |
835 |
$941.88 |
| 82950 |
|
130 |
119 |
$927.53 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,236 |
1,126 |
$907.52 |
| 86706 |
|
76 |
76 |
$894.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
204 |
200 |
$885.51 |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
28 |
28 |
$880.20 |
| 86900 |
|
398 |
383 |
$760.61 |
| 82947 |
|
164 |
163 |
$685.44 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
257 |
234 |
$655.86 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
12 |
12 |
$651.02 |
| 84153 |
|
29 |
28 |
$619.06 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
278 |
261 |
$530.00 |
| 86787 |
|
37 |
37 |
$497.96 |
| 84481 |
|
25 |
24 |
$463.44 |
| 87040 |
|
138 |
136 |
$434.74 |
| 86038 |
|
28 |
27 |
$385.09 |
| 87081 |
|
52 |
52 |
$356.48 |
| 84484 |
|
822 |
733 |
$329.54 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
95 |
83 |
$289.25 |
| 81015 |
|
12 |
12 |
$271.16 |
| 87205 |
|
109 |
105 |
$262.16 |
| 84550 |
|
51 |
51 |
$254.40 |
| 80076 |
|
26 |
25 |
$206.13 |
| 82785 |
|
20 |
13 |
$205.92 |
| 82570 |
|
30 |
29 |
$163.66 |
| 85007 |
|
87 |
84 |
$157.53 |
| 84100 |
|
46 |
43 |
$93.56 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
13 |
13 |
$82.10 |
| 83615 |
|
13 |
13 |
$80.30 |
| 85378 |
|
29 |
29 |
$51.12 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
15 |
15 |
$20.97 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
27 |
27 |
$11.02 |
| J2060 |
Injection, lorazepam, 2 mg |
64 |
58 |
$2.70 |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
92 |
87 |
$0.00 |
| 90715 |
|
18 |
18 |
$0.00 |
| 82553 |
|
17 |
16 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
27 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
65 |
63 |
$0.00 |
| 83605 |
|
41 |
38 |
$0.00 |